Mark Lust

A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease

John Halliday, Jelena Djordjević, Mark Lust et al. · Journal of Crohn s and Colitis · 2011 · 90 citations · Full text

Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial

Julien D. Schulberg, Emily K. Wright, Bronte A. Holt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 59 citations

Gastrointestinal Pharmacology, Gastroenterology, Therapeutic Controversy +6

Addition of thiopurines can recapture response in patients with <scp>C</scp>rohn's disease who have lost response to anti‐tumor necrosis factor monotherapy

David Ong, Michael A. Kamm, Juanda Leo Hartono et al. · Journal of Gastroenterology and Hepatology · 2013 · 40 citations

Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne

Lani Prideaux, Michael A. Kamm, Peter De Cruz et al. · Journal of Gastroenterology and Hepatology · 2011 · 35 citations

Chronic Inflammatory Diseases, Gastroenterology, Population Health Sciences +19

Telehealth model of care for outpatient inflammatory bowel disease care in the setting of the <scp>COVID</scp>‐19 pandemic

Rushab Shah, Emily K. Wright, George Tambakis et al. · Internal Medicine Journal · 2021 · 29 citations · Full text